000919 金陵药业
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.5621.4251.1503.4103.556
总资产报酬率 ROA (%)0.9790.8910.6982.1162.342
投入资产回报率 ROIC (%)1.4631.3251.0853.2613.379

边际利润分析
销售毛利率 (%)21.57820.86118.45819.95619.773
营业利润率 (%)3.5532.1661.3094.6204.868
息税前利润/营业总收入 (%)3.0951.6620.5713.9374.064
净利润/营业总收入 (%)2.8541.6040.5474.0314.263

收益指标分析
经营活动净收益/利润总额(%)72.17858.365121.47368.22355.036
价值变动净收益/利润总额(%)16.76846.152134.99021.615-9.568
营业外收支净额/利润总额(%)-4.667-6.209-7.3820.538-1.755

偿债能力分析
流动比率 (X)3.5413.8913.5232.9823.043
速动比率 (X)3.3133.6523.2582.6952.753
资产负债率 (%)20.08519.72320.37019.67120.186
带息债务/全部投入资本 (%)4.3725.4315.5591.9763.146
股东权益/带息债务 (%)2,153.7211,714.6861,671.2154,859.0283,026.289
股东权益/负债合计 (%)311.142318.871305.665299.352326.399
利息保障倍数 (X)-10.325-4.405-0.881-5.558-5.643

营运能力分析
应收账款周转天数 (天)48.10647.68645.43436.89839.493
存货周转天数 (天)33.82535.90737.84238.11841.661